Dr. Stephen Hazelrigg, MD
Claim this profileMemorial Medical Center
Studies Heart Failure
Studies Left Ventricular Dysfunction
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Stephen Hazelrigg, MD
Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Stephen Hazelrigg, MD has experience with
- Revivent TC
Breakdown of trials Stephen Hazelrigg, MD has run
Heart Failure
Left Ventricular Dysfunction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Hazelrigg, MD specialize in?
Stephen Hazelrigg, MD focuses on Heart Failure and Left Ventricular Dysfunction. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Stephen Hazelrigg, MD currently recruiting for clinical trials?
No, Stephen Hazelrigg, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Stephen Hazelrigg, MD has studied deeply?
Yes, Stephen Hazelrigg, MD has studied treatments such as Revivent TC.
What is the best way to schedule an appointment with Stephen Hazelrigg, MD?
Apply for one of the trials that Stephen Hazelrigg, MD is conducting.
What is the office address of Stephen Hazelrigg, MD?
The office of Stephen Hazelrigg, MD is located at: Memorial Medical Center, Springfield, Illinois 62781 United States. This is the address for their practice at the Memorial Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.